119 results
Page 3 of 6
6-K
EX-99.2
udtr7
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
nbybo
27 Apr 22
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
6:00am
6-K
EX-99.2
67cy9t3 41ehkckiidr
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.3
qmu sotdjucjj
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
78oz73g73vp
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.6
22z m83q0
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
4kbu6uk joblr
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
3v5jacph
7 Feb 22
Current report (foreign)
2:40pm
6-K
EX-99.1
dxgrl ojt6bp
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
9f90mtr4
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.1
5v2lr3
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.2
5i0ylcvxkywitve4sine
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
EX-4.1
axz1bi71 13zis
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.1
hifidetg6r77b7y8x4
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
3cprd2bfjq2r
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
3819c06s
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.2
finhacyfxhuldjf3
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
uyhyal0lv3jrv
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm